In 2007, Grunewald et al. (35) first reported a nuclear localization of LASP1 in 29% of breast carcinoma patients and later on nuclear localization was correlated with a reduced overall survival rate of invasive breast tumor patients (27). This evidence concerns the gene LASP1 and breast carcinoma.